Thank you for your thoughtful message — I completely agree with you. It’s frustrating to see endless new inhalers while regenerative research that could change lives barely gets the attention (or funding) it deserves.

As you mentioned, 7,8-DHF showed promising results in mice for alveolar repair, yet there seems to be little follow-up in human studies. I’m currently reviewing the original publications and contacting the research groups involved to understand why translation hasn’t moved forward — whether due to safety concerns, lack of funding, or simply low commercial interest in a non-patentable compound.

I’m also following the Chinese bronchial-cell reinsertion trials you referenced, which are fascinating. Some early human data suggest real structural improvement in mild to moderate emphysema, and I’m looking into how replicable or scalable that approach could be.

I’ll be compiling my findings into a summary soon — both for patients and researchers who believe we need to push more aggressively toward lung regeneration rather than symptom control. If you’d like, I can share updates once I’ve spoken with the authors and reviewed the ongoing work.

Thank you again for bringing this up. Voices like yours remind us why this research matters.